Zucchi R, Yu G, Ghelardoni S, Ronca F, Ronca-Testoni S
Dipartimento di Scienze dell'Uomo e dell'Ambiente, Sezione di Biochimica, University of Pisa, via Roma 55, I-56126, Pisa, Italy.
Cardiovasc Res. 2001 Apr;50(1):56-64. doi: 10.1016/s0008-6363(00)00318-7.
Stimulation of A3 adenosine receptors has been shown to protect cardiac myocytes from ischemic injury, but the mechanism of this action is unknown. We evaluated the effect of adenosine agonists and antagonists on the sarcoplasmic reticulum (SR) Ca(2+) channels.
Isolated rat hearts were perfused with control buffer or different adenosine agonists and antagonists. Hearts were then homogenized and used to determine SR Ca(2+)-induced Ca(2+) release, assayed by quick filtration technique after loading with 45Ca(2+), and the binding of [3H]ryanodine, a specific ligand of the SR Ca(2+) release channel. In parallel experiments, hearts were challenged with 30 min of global ischemia and 120 min of reperfusion, and the extent of tissue necrosis was evaluated by triphenyltetrazolium chloride staining.
Perfusion with the A1>A3 agonist R-PIA and the A3>A1 agonist IB-MECA was associated with reduced [3H]ryanodine binding, due to reduced B(max) (by about 20%), whereas K(d) and Ca(2+)-dependence of the binding reaction were unaffected. These actions were abolished by the A3 antagonist MRS 1191, while they were not affected by A1 and A2 antagonists. The rate constant of SR Ca(2+) release decreased by 25-30% in hearts perfused with R-PIA or IB-MECA. Tissue necrosis was significantly reduced in the presence of R-PIA or IB-MECA. Protection was removed by MRS 1191, and it was not affected by A1 and A2 antagonists. Hearts were also protected by administration of dantrolene, a ryanodine receptor antagonist. In the presence of dantrolene, no further protection was provided by IB-MECA.
A3 adenosine receptor stimulation modulates the SR Ca(2+) channel. This action might account for the protective effect of adenosine.
已证明刺激 A3 腺苷受体可保护心肌细胞免受缺血损伤,但其作用机制尚不清楚。我们评估了腺苷激动剂和拮抗剂对肌浆网(SR)Ca(2+)通道的影响。
用对照缓冲液或不同的腺苷激动剂和拮抗剂灌注离体大鼠心脏。然后将心脏匀浆,用于测定 SR Ca(2+)诱导的 Ca(2+)释放(通过在加载 45Ca(2+)后采用快速过滤技术进行测定)以及 [3H]ryanodine(SR Ca(2+)释放通道的特异性配体)的结合情况。在平行实验中,对心脏进行 30 分钟的全心缺血和 120 分钟的再灌注处理,并通过氯化三苯基四氮唑染色评估组织坏死程度。
用 A1>A3 激动剂 R-PIA 和 A3>A1 激动剂 IB-MECA 灌注与 [3H]ryanodine 结合减少有关,这是由于 B(max)降低(约 20%),而结合反应的 K(d)和 Ca(2+)依赖性未受影响。这些作用被 A3 拮抗剂 MRS 1191 消除,而不受 A1 和 A2 拮抗剂影响。在用 R-PIA 或 IB-MECA 灌注的心脏中,SR Ca(2+)释放的速率常数降低了 25 - 30%。在存在 R-PIA 或 IB-MECA 的情况下,组织坏死明显减少。MRS 1191 消除了这种保护作用,且不受 A1 和 A2 拮抗剂影响。给予ryanodine 受体拮抗剂丹曲林也可保护心脏。在存在丹曲林的情况下,IB-MECA 不再提供进一步的保护。
刺激 A3 腺苷受体可调节 SR Ca(2+)通道。这一作用可能解释了腺苷的保护作用。